Skip to content
Molecules
SEKISUI XenoTech DD Blog Logo

Year: 2016

Pharmaceutical Outsourcing Magazine Interview Nov-Dec 2016

For their November/December 2016 issue, Pharmaceutical Outsourcing Magazine interviewed Chris Bohl, PhD, Global Technical Support Manager for SEKISUI XenoTech’s Products Division, on...

SEKISUI XenoTech Standardizes Lysosomal Test Systems for Biopharmaceutical Development

Before releasing these test systems, there was not a high quality, specific, relevant, easy and ready to use, in vitro test system to...

SEKISUI XenoTech Joins Fight Against Liver Disease

SEKISUI XenoTech is committed to furthering the knowledge surrounding hepatic diseases, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic...

SEKISUI XenoTech Featured on Labiotech.EU

Understand which transporters are involved in a drug’s absorption, distribution & excretion Originally posted on Labiotech.EU How can you build the...

XenoTech Scientists Publish Paper, Present Research Evaluating Ketoconazole and its Alternative Clinical CYP3A4-5 Inhibitors as Inhibitors of Drug Transporters

SEKISUI XenoTech scientists published a paper in Drug Metabolism and Disposition evaluating Ketoconazole and its alternative clinical CYP3A4-5 inhibitors as inhibitors of drug...

SEKISUI XenoTech Fulfills Largest Order To Date

Sekisui XenoTech recently fulfilled its largest order of human liver subcellular fractions to date. A large pharmaceutical customer ordered over...

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate